Get the Stockscreener App
90.06
0.07%
0.0616
Amedisys Inc stock is traded at $90.06, with a volume of 191.58K.
It is up +0.07% in the last 24 hours and down -7.53% over the past month.
Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.
See More
Previous Close:
$90.00
Open:
$90
24h Volume:
191.58K
Relative Volume:
0.45
Market Cap:
$2.95B
Revenue:
$2.29B
Net Income/Loss:
$91.98M
P/E Ratio:
1,286.59
EPS:
0.07
Net Cash Flow:
$88.47M
1W Performance:
-0.25%
1M Performance:
-7.53%
6M Performance:
-6.39%
1Y Performance:
-3.88%
1-Day Range:
$89.78
$90.16
1-Week Range:
$88.81
$90.47
52-Week Range:
$88.81
$98.95
Amedisys Inc Stock (AMED) Company Profile
Name
Amedisys Inc
Sector
Industry
Phone
(225) 292-2031
Address
3854 AMERICAN WAY, BATON ROUGE, LA
Compare AMED with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| AMED | 90.04 | 2.95B | 2.29B | 91.98M | 88.47M | 0.07 |
| HCA | 332.27 | 82.59B | 69.62B | 5.93B | 5.88B | 20.33 |
| THC | 148.69 | 14.27B | 20.97B | 3.13B | 2.39B | 4.33 |
| DVA | 163.51 | 13.36B | 12.67B | 827.68M | 1.42B | 5.03 |
| UHS | 197.35 | 12.98B | 15.42B | 1.03B | 956.84M | 9.53 |
| FMS | 22.00 | 12.82B | 20.87B | 715.19M | 2.10B | 0.8156 |
Amedisys Inc Stock (AMED) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-07-23 | Downgrade | Truist | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Mar-13-23 | Initiated | Barclays | Equal Weight |
| Oct-27-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-02-22 | Downgrade | UBS | Neutral → Sell |
| Jun-29-22 | Initiated | Stifel | Hold |
| Jun-21-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-01-22 | Upgrade | UBS | Sell → Neutral |
| Feb-25-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-25-22 | Reiterated | Credit Suisse | Outperform |
| Feb-25-22 | Reiterated | Oppenheimer | Outperform |
| Feb-25-22 | Reiterated | RBC Capital Mkts | Outperform |
| Feb-25-22 | Reiterated | Raymond James | Outperform |
| Feb-25-22 | Reiterated | Truist | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-24-21 | Initiated | UBS | Sell |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-10-21 | Reiterated | The Benchmark Company | Buy |
| Aug-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-20-20 | Resumed | Barclays | Overweight |
| Jul-30-20 | Reiterated | The Benchmark Company | Buy |
| Jun-18-20 | Upgrade | The Benchmark Company | Hold → Buy |
| May-07-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-09-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jan-17-20 | Initiated | Credit Suisse | Outperform |
| Nov-01-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-22-19 | Resumed | Stephens | Equal-Weight |
| Sep-17-19 | Initiated | Deutsche Bank | Buy |
| May-02-19 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-14-18 | Initiated | Barclays | Equal Weight |
| Nov-16-18 | Initiated | UBS | Neutral |
| Oct-30-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-03-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-19-18 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Nov-09-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-08-17 | Reiterated | Mizuho | Buy |
| Nov-02-17 | Upgrade | The Benchmark Company | Hold → Buy |
| Aug-21-17 | Initiated | BofA/Merrill | Neutral |
View All
Amedisys Inc Stock (AMED) Latest News
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports - MSN
US sues to block UnitedHealth's $3.3 billion purchase of Amedisys - MSN
Justice Department sues to block UnitedHealth Group's $3.3 billion purchase of Amedisys - MSN
Alpine Associates Management Inc. Decreases Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ sues UnitedHealth amid $3.3 billion bid to buy home care giant Amedisys - MSN
Principal Financial Group Inc. Sells 33,149 Shares of Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
U.S. Justice Department moves to block big healthcare purchase - Nevada Current
DOJ Challenges UnitedHealth And Amedisys Merger - Evrim Ağacı
ACA subsidy optimism and a fiery antitrust speech - STAT
Amedisys stock touches 52-week low at $89.54 amid market shifts - Investing.com
Inside the Justice Department’s Amedisys-Optum Lawsuit - Hospice News
LMR Partners LLP Reduces Stake in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
Amedisys Earnings: An Early Look - AOL
ING Groep NV Cuts Stock Position in Amedisys, Inc. (NASDAQ:AMED) - MarketBeat
DOJ Lawsuit Questions UnitedHealth's $3.3 Billion Amedisys Deal - MSN
Justice Department and four Attorneys General block $3.3 billion acquisition of Amedisys Inc. - MSN
DOJ is suing to block UnitedHealth's $3.3 billion purchase of Amedisys - Fortune
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape - AOL
Evaluating The DOJ’s Arguments Against The UnitedHealth Group-Amedisys Deal - Home Health Care News
Justice Department sues to block UnitedHealth Group’s $3.3 billion purchase of Amedisys - Nashua Telegraph
DOJ Sues to Stop UnitedHealth's Amedisys Acquisition - Newser
Juniper Networks falls as DOJ sues to block Amedisys sale to UnitedHealth - MSN
DOJ files lawsuit to block UnitedHealth from purchasing Amedisys - The San Joaquin Valley Sun
DOJ sues to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
DOJ sues to block UnitedHealth’s acquisition of Amedisys - Business Insurance
DOJ sues to block UnitedHealth's acquisition of Amedisys - Healthcare Finance News
$3B Health Care Merger Would Be Bad For New Jersey, Other States: Feds - Patch
New York Attorney General Letitia James joins lawsuit against UnitedHealth Group merger - CNYcentral.com
DOJ prepares lawsuit to block UnitedHealth Group’s acquisition of Amedisys - BenefitsPro
Justice Department sues to block United Health merger with Amedisys - ConsumerAffairs
UnitedHealth-Amedisys merger targeted by Justice Department - The Business Journals
DOJ sues UnitedHealth/Amedisys to shut down “massive healthcare ecosystem” - Global Competition Review
New York attorney general joins lawsuit to block UnitedHealth, Amedisys merger - MSN
Why UnitedHealth, Amedisys are standing behind their deal - Modern Healthcare
Justice Department Blocks UnitedHealth's Amedisys Acquisition - Evrim Ağacı
Amedisys Inc Stock (AMED) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.09%
1.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):